Charles River Laboratories | CRL - Selling And Administration Expenses


Charles River Laboratories reported $140.59M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
Align Technology USD 410.55M 52.12M Sep/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 226.5M 12.4M Sep/2026
Cardinal Health USD 1.6B 30M Sep/2026
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Cigna USD 3.61B 142M Sep/2026
Concord Medical Services Hldg CNY 124.78M 15.58M Dec/2025
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 363M 1000K Sep/2026
Elevance Health USD 10.91B 309M Dec/2025
Humana USD 3.36B 614M Mar/2025
Illumina USD 281M 8M Sep/2026
Incyte USD 364.27M 12.54M Sep/2026
Intrexon USD 10.31M 41K Jun/2024
IQVIA Holdings USD 569M 5M Sep/2026
Laboratory Of America USD 611.4M 34.2M Sep/2026
Lakefront Biotherapeutics EUR 22.5M 13M Jun/2026
McKesson USD 2.27B 5M Sep/2026
Merck EUR 1.58B 11M Sep/2026
Mettler Toledo International USD 267.16M 3.82M Sep/2026
Novartis USD 3.08B 163M Sep/2026
Pfizer USD 3.28B 132M Sep/2026
Quest Diagnostics USD 523M 6M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
United Therapeutics USD 184.1M 22.6M Sep/2026
UnitedHealth USD 15.22B 1.44B Sep/2025
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 398M 7M Sep/2026
West Pharmaceutical Services USD 112.9M 4.7M Sep/2026